Laser Treatment

What Is Laser Treatment?

IntimaLase ®  is a unique, Er:YAG laser therapy for incisionless, non-invasive photothermal tightening of the vaginal canal.

USP

• US FDA approved
• Incisionless
• Non-invasive
• Non-surgical
• Non-ablative
• Preset
• Rewarding
• Top-of-the-line technology
• High patient satisfaction
• High precision
• No downtime
• Efficiant
• Easy-to-perform
• Safer
• Faster
• Walk-in and walk-out procedure
• More patient friendly
• Backed by clinical studies

Procedure:

• No special pre-op preparation or post-op precautions are necessary.
• Procedure is done by insertion of the speculum into the vaginal canal, insertion of the laser handpiece with circular adapter onto the speculum.
• Treatment of the vaginal canal with the circular adapter, direct treatment of the introitus and vestibulum.
• By doing this new collagen is formed that strengthens the vaginal wall, normal function and structure of vaginal tissue is restored.
• New vessels are formed

INDICATION

vaginal relaxation syndrome, which is the loss of the optimum structural form of the vagina. This condition is generally associated with overstretching of the vaginal canal during childbirth as well as with natural aging.

How does intimalase work?

• The Erbium Yag(2940 nm) laser works by emitting short pulses of energy that causes the water molecules to heat up and break down.
• The heat from the laser also stimulates collagen remodeling and synthesis of new collagen fibers in the vaginal mucosa tissue and collagen-rich rndopelvic fascia., which helps reduce laxity and other signs of aging.
• The final result of collagen neogenesis and remodeling is tightening of the vaginal canal.

Sessions

Treatment sessions 2 to 3 sessions with a gap pf 4 to 6 weeks, 30 minutes procedure.

Exceptional clinical results

• 95% assessed the change of their vaginal tightness as strongly or moderately improved after IntimaLase treatment.
• Average shrinkage of vaginal canal after IntimaLase treatment was 17%.
• High level of patient satisfaction (97%).

‍